Katja Jansen

Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade

The role of liquid–liquid phase separation in aggregation of the TDP-43 low-complexity domain

Curcumin binds to the α‐helical intermediate and to the amyloid form of prion protein – a new mechanism for the inhibition of PrP^Sc accumulation

The Crystal Structure of the Globular Domain of Sheep Prion Protein

Time‐dependent insulin oligomer reaction pathway prior to fibril formation: Cooling and seeding

Assembly of Amyloid Protofibrils via Critical Oligomers—A Novel Pathway of Amyloid Formation

Progress towards structural understanding of infectious sheep PrP-amyloid

Effect of metal ions on de novo aggregation of full-length prion protein

Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases

Protein Misfolding, Functional Amyloid, and Human Disease

Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)

Mechanisms of prion protein assembly into amyloid

Acidic pH and Detergents Enhance in Vitro Conversion of Human Brain PrPC to a PrPSc-like Form

The Structural Transition of the Prion Protein into its Pathogenic Conformation is Induced by Unmasking Hydrophobic Sites

Structural Intermediates in the Putative Pathway from the Cellular Prion Protein to the Pathogenic Form